5HT2A and 5HT2C receptor polymorphisms and predicting clinical response to olanzapine in schizophrenia
- PMID: 12454564
- DOI: 10.1097/00004714-200212000-00014
5HT2A and 5HT2C receptor polymorphisms and predicting clinical response to olanzapine in schizophrenia
Similar articles
-
Effects of olanzapine plasma concentrations on depressive symptoms in schizophrenia: a pilot study.J Clin Psychopharmacol. 2002 Oct;22(5):530-2. doi: 10.1097/00004714-200210000-00019. J Clin Psychopharmacol. 2002. PMID: 12352282 No abstract available.
-
5-HT2A receptor promoter polymorphism, -1438G/A and negative symptom response to olanzapine in schizophrenia.Psychopharmacol Bull. 2003 Spring;37(2):109-12. Psychopharmacol Bull. 2003. PMID: 14566219 Clinical Trial.
-
Olanzapine: an updated review of its use in the management of schizophrenia.Drugs. 2001;61(1):111-61. doi: 10.2165/00003495-200161010-00011. Drugs. 2001. PMID: 11217867 Review.
-
Olanzapine versus other antipsychotics in the treatment of schizophrenia.J Clin Psychiatry. 2001 Oct;62(10):828-9. doi: 10.4088/jcp.v62n1012c. J Clin Psychiatry. 2001. PMID: 11816875 No abstract available.
-
Olanzapine: a basic science update.Br J Psychiatry Suppl. 1999;(37):36-40. Br J Psychiatry Suppl. 1999. PMID: 10211140 Review.
Cited by
-
The impact of atypical antipsychotic use on obstructive sleep apnea: a pilot study and literature review.Sleep Med. 2011 Jun;12(6):591-7. doi: 10.1016/j.sleep.2010.12.013. Sleep Med. 2011. PMID: 21645873 Free PMC article. Review.
-
Effects of clozapine and 2,5-dimethoxy-4-methylamphetamine [DOM] on 5-HT2A receptor expression in discrete brain areas.Pharmacol Biochem Behav. 2005 Aug;81(4):750-7. doi: 10.1016/j.pbb.2005.05.011. Pharmacol Biochem Behav. 2005. PMID: 15972234 Free PMC article.
-
Pharmacogenetics of antipsychotics.Can J Psychiatry. 2014 Feb;59(2):76-88. doi: 10.1177/070674371405900203. Can J Psychiatry. 2014. PMID: 24881126 Free PMC article. Review.
-
Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction.Expert Opin Drug Metab Toxicol. 2011 Jan;7(1):9-37. doi: 10.1517/17425255.2011.532787. Expert Opin Drug Metab Toxicol. 2011. PMID: 21162693 Free PMC article. Review.
-
Intramuscular olanzapine: a review of its use in the management of acute agitation.CNS Drugs. 2005;19(2):147-64. doi: 10.2165/00023210-200519020-00005. CNS Drugs. 2005. PMID: 15697328 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical